Clinical trials
Adult clinical trials
Below are recruiting adult clinical trials, each written for real people, not researchers. We’re tracking 3,745 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07173972RecruitingPhase 2
Proton radiation for inoperable soft tissue sarcoma
This trial studies a high-dose, shortened course of proton beam radiation for people with soft tissue sarcoma that cannot be removed by surgery. It aims to improve tumor control while reducing side effects.
BergenAges 18 years+ - NCT07167225Recruiting
Chemical exposure in young adults who use e-cigarettes and cannabis
This study looks at how young adults who use e-cigarettes, cannabis, or both are exposed to harmful chemicals. It aims to understand the health effects of using these products together.
Buffalo, New YorkAges 18–25 - NCT07169747RecruitingPhase 2
Psilocybin with therapy for young adults with anorexia
This study tests two different doses of psilocybin, a substance that may help change thinking patterns, given alongside psychological support to young adults with anorexia nervosa. It aims to see if it is safe and helpful for weight recovery and mental health.
LundAges 16–35 - NCT05525923Recruiting
Personalized pain plan after chest surgery in adults
This trial tests a personalized (tailored) plan to manage pain after thoracic (chest) surgery. It may help improve comfort and recovery by matching pain treatment to your situation after surgery.
Pittsburgh, PennsylvaniaAges 18–99 - NCT05452694Recruiting
Personalized pain relief after back fusion surgery
This trial tests a personalized plan to manage pain after lumbar (lower back) fusion and decompression surgery. It may help reduce difficult pain while guiding safe use of opioids around the time of surgery.
Pittsburgh, PennsylvaniaAges 18–99 - NCT05836688Recruiting
Biobehavioral program to help young testicular cancer survivors
This study tests a counseling-style (biobehavioral) program to help reduce upsetting outcomes in young adult testicular cancer survivors. It focuses on people who feel high distress after treatment and aims to improve well-being and coping.
Irvine, CaliforniaAges 18–39 - NCT06953908Recruiting
The Copenhagen Gender Identity Study
This trial follows all patients referred to the Center for Gender Identity in Copenhagen to learn more about their experiences and needs. If you are referred there and can read Danish, you may join.
CopenhagenAges 18 years+ - NCT07163728Recruiting
Leptin as a marker for chemo sensitivity in new AML
This study is looking at a substance called leptin in the blood of people with newly diagnosed acute myeloid leukemia (AML). The goal is to see if leptin levels can help doctors predict how well chemotherapy will work, which could guide better treatment choices.
Fuzhou, FujianAges 18 years+ - NCT07156708Recruiting
Aquatic exercise with brain games for older women
This trial tests if doing exercise in water combined with mental tasks can improve health for physically inactive older women. It may help you stay active and sharp.
Pelotas, Rio Grande do SulAges 60–75 - NCT07161726RecruitingPhase 1/Phase 2
Cocoa and exercise for older adults
This trial tests whether eating cocoa can boost the benefits of a supervised exercise program for older adults who walk a bit more slowly. You could help find out if this natural product makes exercise work better.
Birmingham, AlabamaAges 55 years+ - NCT07163819RecruitingPhase 2
Probiotics for digestive health during short trips abroad
This study tests whether taking a probiotic can help prevent or reduce digestive issues when traveling abroad for less than a week. It aims to see if probiotics support overall health during short overseas trips.
Haidian, Beijing MunicipalityAges 18–65 - NCT07157631Recruiting
Tranexamic acid for adults having liver transplant
This trial tests if tranexamic acid, a medicine that helps blood clot, can safely reduce bleeding during adult liver transplant surgery.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07164131RecruitingPhase 4
Comparing two antibiotics for hospitalized pneumonia patients
This trial compares two antibiotics, azithromycin and doxycycline, when given alongside a standard beta-lactam antibiotic to hospitalized adults with community-acquired pneumonia. It aims to see which combination works better and is safer.
Scottsdale, ArizonaAges 18 years+ - NCT07158047Recruiting
Far Infrared Sauna Therapy for Obesity
This study tests whether regular far infrared sauna sessions can help people with obesity improve their health. You would sit in a special sauna several times a week to see if it affects your weight, blood pressure, or other health measures.
Eugene, OregonAges 18–59 - NCT07157774RecruitingPhase 3
Muvalaplin for heart disease in people with high lipoprotein(a)
This study tests a new medicine called muvalaplin that lowers a specific type of cholesterol linked to heart disease. It aims to see if muvalaplin can reduce the risk of future heart attacks, strokes, or related procedures in people with high levels of this cholesterol.
Birmingham, AlabamaAges 18 years+ - NCT07157787RecruitingPhase 2
Testing a new drug for primary membranous nephropathy
This trial tests a new drug called ALXN1920 for adults with primary membranous nephropathy (PMN), a kidney disease where the immune system attacks the kidneys. It is for people at high risk of their disease getting worse, and it compares the new drug added to standard care versus standard care alone.
Loma Linda, CaliforniaAges 18–75 - NCT07155187RecruitingPhase 2/Phase 3
Study of telisotuzumab adizutecan for EGFR-mutated lung cancer
This trial tests a new drug, telisotuzumab adizutecan (given through a vein), alone or with another targeted therapy, versus standard treatments for people with a specific type of advanced lung cancer that has an EGFR mutation and has gotten worse after previous treatment.
Springdale, ArkansasAges 18 years+ - NCT07161414RecruitingPhase 1
Study of rilvegostomig for advanced solid tumors
This study tests a new investigational drug, rilvegostomig, given as an injection under the skin. It is for people with advanced solid tumors that have not responded to or have progressed after standard treatments. The goal is to see how the drug behaves in the body and to assess its safety.
Huntersville, North CarolinaAges 18 years+ - NCT07162441RecruitingPhase 1
Drug interaction study in healthy volunteers
This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.
Seoul, Gwanak-guAges 19 years+ - NCT07160179RecruitingPhase 1/Phase 2
Study of an eye injection for geographic atrophy
This study tests a new medicine (ABBV-6628) given as an injection into the eye to see how well it works and how it moves through the body for people with geographic atrophy (an advanced form of dry age-related macular degeneration). It may help slow vision loss from this condition.
Carmel, IndianaAges 50 years+ - NCT07161180RecruitingPhase 1
Study of PBK_M2301 in Healthy Adults
This trial tests how a new medicine, PBK_M2301, moves through the body in healthy adults. It aims to find out how the drug is absorbed and eliminated to guide future studies.
Seoul, SeoulAges 19–65 - NCT07156916RecruitingPhase 1
Tamsulosin tablet comparison study in healthy men
This trial tests how a new tamsulosin tablet (used for prostate problems) compares to the standard drug in healthy men. You will take one dose and have blood samples taken to measure the drug levels.
Yerevan, Ankuk RegionAges 18–45 - NCT07156175RecruitingPhase 2
Study of new treatment for microscopic colitis in remission
This study tests whether a new medication (SAR444336) can help adults with microscopic colitis stay in remission longer. It may be an option if you are already taking budesonide and have had flares in the past 8 months.
LeuvenAges 18 years+ - NCT07160608RecruitingPhase 2
Study of Tarperprumig for ANCA-associated vasculitis
This trial tests a new drug (tarperprumig) for people with active ANCA-associated vasculitis (GPA or MPA). The goal is to see if it is safe and effective for treating the disease, especially when standard treatments like rituximab or cyclophosphamide are being considered.
Ciudad de Buenos AiresAges 18–80
Hear when a new Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for adult?
- Yes. Clin2 currently lists 3,745 recruiting adult studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a adult trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a adult trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.